These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

461 related items for PubMed ID: 24598218

  • 1. Estimation of kidney injury molecule-1 (Kim-1) in patients with lupus nephritis.
    Nozaki Y, Kinoshita K, Yano T, Shiga T, Hino S, Niki K, Kishimoto K, Funauchi M, Matsumura I.
    Lupus; 2014 Jul; 23(8):769-77. PubMed ID: 24598218
    [Abstract] [Full Text] [Related]

  • 2. U-KIM-1 as a predictor of treatment response in lupus nephritis.
    Nozaki Y, Shiga T, Ashida C, Tomita D, Itami T, Kishimoto K, Kinoshita K, Matsumura I.
    Lupus; 2023 Jan; 32(1):54-62. PubMed ID: 36305170
    [Abstract] [Full Text] [Related]

  • 3. Composite urinary biomarkers to predict pathological tubulointerstitial lesions in lupus nephritis.
    Ding Y, Nie LM, Pang Y, Wu WJ, Tan Y, Yu F, Zhao MH.
    Lupus; 2018 Oct; 27(11):1778-1789. PubMed ID: 30020021
    [Abstract] [Full Text] [Related]

  • 4. Urinary kidney injury molecule-1 in patients with IgA nephropathy is closely associated with disease severity.
    Xu PC, Zhang JJ, Chen M, Lv JC, Liu G, Zou WZ, Zhang H, Zhao MH.
    Nephrol Dial Transplant; 2011 Oct; 26(10):3229-36. PubMed ID: 21402675
    [Abstract] [Full Text] [Related]

  • 5. Urine Galectin-3 binding protein reflects nephritis activity in systemic lupus erythematosus.
    Faustini F, Idborg H, Fuzzi E, Larsson A, Lie WR, Pötzsch S, Okitsu SL, Svenungsson E, Gunnarsson I.
    Lupus; 2023 Feb; 32(2):252-262. PubMed ID: 36508734
    [Abstract] [Full Text] [Related]

  • 6. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
    Adhya Z, El Anbari M, Anwar S, Mortimer A, Marr N, Karim MY.
    Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
    [Abstract] [Full Text] [Related]

  • 7. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
    Peters HP, Waanders F, Meijer E, van den Brand J, Steenbergen EJ, van Goor H, Wetzels JF.
    Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
    [Abstract] [Full Text] [Related]

  • 8. Urinary sCD25 as a biomarker of lupus nephritis disease activity.
    Gupta R, Yadav A, Misra R, Aggarwal A.
    Lupus; 2015 Mar; 24(3):273-9. PubMed ID: 25305215
    [Abstract] [Full Text] [Related]

  • 9. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients.
    He D, Liu M, Liu B.
    Tohoku J Exp Med; 2018 Apr; 244(4):263-270. PubMed ID: 29576585
    [Abstract] [Full Text] [Related]

  • 10. Kidney Injury Molecule-1 Level is Associated with the Severity of Renal Interstitial Injury and Prognosis in Adult Henoch-Schönlein Purpura Nephritis.
    Zhang Y, Li A, Wen J, Zhen J, Hao Q, Zhang Y, Hu Z, Xiao X.
    Arch Med Res; 2017 Jul; 48(5):449-458. PubMed ID: 29122357
    [Abstract] [Full Text] [Related]

  • 11. The role of urinary neutrophil gelatinase-associated lipocalin in lupus nephritis.
    Alharazy SM, Kong NC, Mohd M, Shah SA, Abdul Gafor AH, Ba'in A.
    Clin Chim Acta; 2013 Oct 21; 425():163-8. PubMed ID: 23954775
    [Abstract] [Full Text] [Related]

  • 12. Tubular kidney injury molecule-1 (KIM-1) in human renal disease.
    van Timmeren MM, van den Heuvel MC, Bailly V, Bakker SJ, van Goor H, Stegeman CA.
    J Pathol; 2007 Jun 21; 212(2):209-17. PubMed ID: 17471468
    [Abstract] [Full Text] [Related]

  • 13. Urine biomarkers of chronic kidney damage and renal functional decline in childhood-onset systemic lupus erythematosus.
    Brunner HI, Gulati G, Klein-Gitelman MS, Rouster-Stevens KA, Tucker L, Ardoin SP, Onel KB, Mainville R, Turnier J, Aydin POA, Witte D, Huang B, Bennett MR, Devarajan P.
    Pediatr Nephrol; 2019 Jan 21; 34(1):117-128. PubMed ID: 30159624
    [Abstract] [Full Text] [Related]

  • 14. Kidney injury molecule-1 expression in human kidney transplants with interstitial fibrosis and tubular atrophy.
    Nogare AL, Veronese FV, Carpio VN, Montenegro RM, Pedroso JA, Pegas KL, Gonçalves LF, Manfro RC.
    BMC Nephrol; 2015 Feb 13; 16():19. PubMed ID: 25884518
    [Abstract] [Full Text] [Related]

  • 15. Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial.
    Waanders F, Vaidya VS, van Goor H, Leuvenink H, Damman K, Hamming I, Bonventre JV, Vogt L, Navis G.
    Am J Kidney Dis; 2009 Jan 13; 53(1):16-25. PubMed ID: 18823687
    [Abstract] [Full Text] [Related]

  • 16. Kidney injury molecule-1 expression in transplant biopsies is a sensitive measure of cell injury.
    Zhang PL, Rothblum LI, Han WK, Blasick TM, Potdar S, Bonventre JV.
    Kidney Int; 2008 Mar 13; 73(5):608-14. PubMed ID: 18160964
    [Abstract] [Full Text] [Related]

  • 17. Urinary prostaglandin D synthase as biomarker in lupus nephritis: a longitudinal study.
    Gupta R, Yadav A, Misra R, Aggarwal A.
    Clin Exp Rheumatol; 2015 Mar 13; 33(5):694-8. PubMed ID: 26211517
    [Abstract] [Full Text] [Related]

  • 18. Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus.
    Soliman SA, Haque A, Vanarsa K, Zhang T, Ismail F, Lee KH, Pedroza C, Greenbaum LA, Mason S, Hicks MJ, Wenderfer SE, Mohan C.
    Front Immunol; 2022 Mar 13; 13():885307. PubMed ID: 35720325
    [Abstract] [Full Text] [Related]

  • 19. Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis.
    Urrego T, Ortiz-Reyes B, Vanegas-García AL, Muñoz CH, González LA, Vásquez G, Gómez-Puerta JA.
    Reumatol Clin (Engl Ed); 2020 Mar 13; 16(1):17-23. PubMed ID: 29530762
    [Abstract] [Full Text] [Related]

  • 20. Urine neutrophil gelatinase-associated lipocalin to predict renal response after induction therapy in active lupus nephritis.
    Satirapoj B, Kitiyakara C, Leelahavanichkul A, Avihingsanon Y, Supasyndh O.
    BMC Nephrol; 2017 Aug 04; 18(1):263. PubMed ID: 28778196
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.